Tag: MedMastodon
-
Are All DOACs Created Equal for Managing Atrial Fibrillation? New study: Yes, when it comes to efficacy. For safety, Apixaban (Eliquis) is associated with less GI bleedings, but since the absolute percentage of GI bleedings is 2-3,5%, it may only give a marginal clinical benefit to choose Apixaban over the other DOACshttps://www.jwatch.org/na55472/2022/11/08/are-all-doacs-created-equal-managing-atrial-fibrillation#dklæger #MedMastodon
-
How can Simulations-based training improve human factor skills of health care workers? New systematic review on the areahttps://advancesinsimulation.biomedcentral.com/articles/10.1186/s41077-022-00207-2#simulation #MedMastodon #dklæger
